首页> 外文期刊>Experimental and clinical transplantation >Single Center Long-Term Results of Pediatric Liver Transplantation
【24h】

Single Center Long-Term Results of Pediatric Liver Transplantation

机译:单中心的小儿肝移植长期结果

获取原文
           

摘要

Objectives: Liver replacement continues to be the only definitive mode of therapy for children with end-stage liver disease. However, it remains challenging because of the rare donor organs, complex surgical demands, and the necessity to prevent long-term complications. Our objectives were to analyze 16 years of experience in the Shiraz University Organ Transplant Center. Materials and Methods: We retrospectively analyzed the records of 752 patients ( 18 years old) who underwent orthotopic liver transplant at our center over a 16-year period. Mean age was 90 months, and male-to-female ratio was 1.25. Of the 752 transplants, 354 were whole organs, 311 were from living related donors, and 87 were in situ split liver allografts. Patient and graft survival rates were determined at 1, 3, and 5 years, and results between groups were compared. Results: Overall mortality was 31.8%. The 1-, 3-, and 5-year patient survival rates were 77%, 69%, and 66%, respectively, whereas the respective graft survival rates were 75%, 68%, and 65%. We observed significant differences in survival according to graft type (log-rank test, P .001). We also observed significant differences in survival probabilities according to age (log-rank test, P .001). Cox regression was used to simultaneously analyze effects of age and graft type on survival. Both graft type and age significantly affected survival ( P .001). The 1-, 3, and 5-year survival rates for patients having whole organ transplants were 88%, 81%, and 78%. Patients who received living donor grafts had respective survival rates of 66%, 60%, and 58%, with rates of 65%, 47%, and 47% for patients who received split grafts. Conclusions: Our results were similar to those observed in the literature in terms of indication for transplant and posttransplant survival.
机译:目的:肝脏替代仍然是患有终级肝病的儿童的唯一明确的疗法模式。然而,由于罕见的供体器官,复杂的手术要求以及预防长期并发症的必要性,它仍然具有挑战性。我们的目标是分析Shiraz Universom器官移植中心的16年经验。材料和方法:我们回顾性分析了752名患者(<18岁)的记录,在16年期间接受了在我们的中心的原位肝脏移植的患者。平均年龄为90个月,男女比例为1.25。在752例移植中,354例是整个器官,311来自生活相关捐赠者,87个原位分裂肝同种异体移植物。患者和移植物存活率在1,3和5年内测定,比较了基团的结果。结果:总体死亡率为31.8%。 1-,3-和5年的患者存活率分别为77%,69%和66%,而相应的移植物存活率为75%,68%和65%。根据接枝型(对数级测试,P <.001),我们观察到存活的显着差异。我们还观察到根据年龄(Log-Rank Test,P <.001)的存活概率的显着差异。 Cox回归用于同时分析年龄和移植物类型对存活的影响。移植型和年龄均显着影响生存(P <.001)。整个器官移植患者的1-,3和5年生存率为88%,81%和78%。接受活性捐赠者移植物的患者的生存率为66%,60%和58%,率为65%,47%和47%,对于接受分裂移植物的患者。结论:我们的结果与文献中观察到的移植和后移植后生存期观察的结果类似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号